Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -140,729 | -74,064 | -33,709 | -25,872 | -11,073 |
| Depreciation Amortization | 834 | 442 | 223 | 144 | N/A |
| Accounts payable and accrued liabilities | 10,507 | 6,953 | 1,946 | 160 | N/A |
| Other Working Capital | 5,270 | 728 | -39 | 1,330 | 2,375 |
| Other Operating Activity | 1,368 | 3,885 | 2,119 | 1,019 | 1,721 |
| Operating Cash Flow | $-122,750 | $-62,056 | $-29,460 | $-23,219 | $-6,977 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -24,585 | -86,426 | -109,911 | -4,053 | N/A |
| PPE Investments | -3,385 | -722 | -133 | -1,057 | -17 |
| Investing Cash Flow | $-27,970 | $-87,148 | $-110,044 | $-5,110 | $-17 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 163,474 | 164,686 | 126,358 | N/A | 2,094 |
| Other Financing Activity | 0 | 0 | 40,842 | 0 | 39,617 |
| Financing Cash Flow | $163,474 | $164,686 | $167,200 | $N/A | $41,711 |
| Beginning Cash Position | 49,943 | 34,461 | 6,765 | 35,094 | 152 |
| End Cash Position | 62,697 | 49,943 | 34,461 | 6,765 | 34,869 |
| Net Cash Flow | $12,754 | $15,482 | $27,696 | $-28,329 | $34,717 |
| Free Cash Flow | |||||
| Operating Cash Flow | -122,750 | -62,056 | -29,460 | -23,219 | -6,977 |
| Capital Expenditure | -3,385 | -722 | -133 | -1,057 | -17 |
| Free Cash Flow | -126,135 | -62,778 | -29,593 | -24,276 | -6,994 |